OMICS-based personalized oncology: if it is worth

doing, it is worth doing well! PDF

Core figure

Discussion

• Niche Buster - Open Innovation - Chemicald을 개방.
  • Compensation을 무엇으로 하는가?
  • Companion Diagnostics로 biomarker. - Genotype을 가지고.
  • Biomarker . 진단약, 진단시약을 개발하는데.

Reference

• Institute of Medicine: Evolution of Translational omics: Lessons Learned and the Path Forward. Washington, DC: The National Academies Press; 2012. http://www.nap.edu/read/13297/chapter/6#82